Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents.
about
Increased risk of SSEs in bone-only metastatic breast cancer patients treated with zoledronic acid.Treatment dynamics of bone-targeting agents among men with bone metastases from prostate cancer in the United States.Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States.microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11.
P2860
Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Risk Factors for Developing Sk ...... nt With Bone-Modifying Agents.
@en
type
label
Risk Factors for Developing Sk ...... nt With Bone-Modifying Agents.
@en
prefLabel
Risk Factors for Developing Sk ...... nt With Bone-Modifying Agents.
@en
P2093
P2860
P1433
P1476
Risk Factors for Developing Sk ...... nt With Bone-Modifying Agents.
@en
P2093
Akihiro Hirakawa
Chikako Shimizu
Fumie Kinoshita
Harukaze Yamamoto
Jun Hashimoto
Kan Yonemori
Kenji Tamura
Makoto Kodaira
Manabu Fujimoto
Mayu Yunokawa
P2860
P304
P356
10.1634/THEONCOLOGIST.2015-0377
P577
2016-03-14T00:00:00Z